Cite
HARVARD Citation
Yang, M. et al. (n.d.). Overcoming erlotinib resistance with tailored treatment regimen in patient‐derived xenografts from naïve Asian NSCLC patients1. International journal of cancer. 132 (2), pp. E74-E84. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Yang, M. et al. (n.d.). Overcoming erlotinib resistance with tailored treatment regimen in patient‐derived xenografts from naïve Asian NSCLC patients1. International journal of cancer. 132 (2), pp. E74-E84. [Online].